Zeleris

RSS

florfenicol / meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Zeleris.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Zeleris.

For practical information about using Zeleris, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 30/05/2017

Authorisation details

Product details
Name
Zeleris
Agency product number
EMEA/V/C/004099
Active substance
  • florfenicol
  • meloxicam
International non-proprietary name (INN) or common name
florfenicol / meloxicam
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
QJ01BA99
Publication details
Marketing-authorisation holder
CEVA Santé Animale
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
15/05/2017
Contact address
10, avenue de La Ballastière
33500 Libourne
France

Product information

15/05/2017 Zeleris - EMEA/V/C/004099 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • ANTIBACTERIALS FOR SYSTEMIC USE
  • AMPHENICOLS
  • combinations

Therapeutic indication

For therapeutic treatment of bovine respiratory disease (BRD) associated with pyrexia due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni susceptible to florfenicol.

Assessment history

How useful was this page?

Add your rating